Drug Profile
Neosaxitoxin
Alternative Names: NeoSTXLatest Information Update: 31 Mar 2020
Price :
$50
*
At a glance
- Originator Childrens Hospital Boston; Proteus S.A.; University of Chile
- Developer Childrens Hospital Boston; Grunenthal; Proteus S.A.; University of Chile
- Class Alkaloids; Analgesics; Biological toxins; Local anaesthetics; Marine toxins; Purines; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Anaesthesia
Highest Development Phases
- Discontinued Anaesthesia
Most Recent Events
- 31 Mar 2020 Discontinued - Phase-I for Anaesthesia (In volunteers) in USA (SC)
- 31 Mar 2020 Discontinued - Phase-I for Anaesthesia in Netherlands (SC)
- 31 Mar 2020 Discontinued - Phase-II for Anaesthesia in Chile (SC)